UNSPSC 51151608: Dicyclomine or dicycloverine

This classification denotes an antimuscarinic agent with the molecular formula C19H35NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 4KV4X8IF6V, chemically known as cyclohexanecarboxylic acid, 1-cyclohexyl-, 2-(diethylamino)ethyl ester but more generally known as dicyclomine, which bears US NIH Compound Identifier 3042. European Medicines Agency schedules Dicycloverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07103MIG.

UNSPSC 51151608 Dicyclomine or dicycloverine is a Commodity code that nominally covers a specific pharmaceutical active ingredient, but the recent state and local procurement activity under this code shows a substantial mismatch: the single identifiable recent opportunity is Seminole County, Florida's IFB60459723LAS, which solicits naloxone and safe drug deactivation systems—products unrelated to dicyclomine's therapeutic scope. The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract requires electronic bid submission, includes drug-free workplace and E-Verify compliance, and carries a two-year initial term with a one-year renewal option. Vendors must provide unit costs, maintain specified insurance coverage, and assume all shipping and delivery costs in their proposals. The procurement is potentially FEMA-funded and includes a three-month probationary period permitting termination by the county with or without cause.

Activity under this code appears minimal and misaligned with its pharmaceutical classification. The Seminole County opportunity posted June 30, 2026 with a response deadline of July 26, 2023—a date inconsistency that may reflect posting or data-entry error—represents the only recent state and local solicitation identifiable under the code. Geographic focus is limited to Florida in the available record. The mismatch between the code's nominal scope (dicyclomine hydrochloride, an anticholinergic medication) and the actual procurement (naloxone, an opioid antagonist, and drug deactivation equipment) suggests either miscoding in the county's procurement system or a data integration error. Firms should verify current coding alignment before pursuing opportunities listed under this code.